Abstract
The defibrinating agent ancrod (Arvin) was used instead of heparin for intermittent haemodialysis. It was an effective, and apparently safe, anticoagulant and reduced the deposition of fibrin and leucocytes on the Cellophane membrane. Administration was more complicated and urea dialysance was less with ancrod than with heparin.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bell W. R., Pitney W. R., Goodwin J. F. Therapeutic defibrination in the treatment of thrombotic disease. Lancet. 1968 Mar 9;1(7541):490–493. doi: 10.1016/s0140-6736(68)91465-7. [DOI] [PubMed] [Google Scholar]
- REID H. A., THEAN P. C., CHAN K. E., BAHAROM A. R. Clinical effects of bites by Malayan viper (Ancistrodon rhodostoma). Lancet. 1963 Mar 23;1(7282):617–621. doi: 10.1016/s0140-6736(63)91268-6. [DOI] [PubMed] [Google Scholar]
- STIRLAND R. M. A rapid method of estimating fibrinogen. Lancet. 1956 May 12;270(6924):672–672. doi: 10.1016/s0140-6736(56)90699-7. [DOI] [PubMed] [Google Scholar]
- Sharp A. A., Warren B. A., Paxton A. M., Allington M. J. Anticoagulant therapy with a purified fraction of Malayan pit viper venom. Lancet. 1968 Mar 9;1(7541):493–499. doi: 10.1016/s0140-6736(68)91466-9. [DOI] [PubMed] [Google Scholar]